Bidirectional regulation of PI3 K/AKT signaling by traditional Chinese medicine-derived monomeric compounds in osteoarthritis: mechanisms and therapeutic potential
Year: 2026
Type: article
Abstract: Osteoarthritis (OA) is a chronic joint disease characterized primarily by articular cartilage degeneration and structural damage. Its development and progression involve multiple pathological processes, including chondrocyte apoptosis, dysregulated autophagy, oxidative stress, inflammation, and disturbed extracellular matrix metabolism. Current OA treatments mainly focus on relieving symptoms and improving joint function, while effective therapeutic strategies to slow cartilage degeneration remain to be established. The phosphoinositide 3-kinase/protein kinase B (PI3 K/AKT) signaling pathway plays an important role in regulating chondrocyte survival, metabolism, and stress responses. Growing evidence indicates that traditional Chinese medicine-derived monomeric compounds can exert chondroprotective effects through bidirectional modulation of PI3 K/AKT signaling. However, existing research lacks sufficient comparative analysis and discussion of the mechanisms and differences underlying the chondroprotective effects of these compounds through different directions of pathway modulation. This narrative review outlines the molecular mechanisms and biological roles of PI3 K/AKT signaling in OA development and progression, summarizes advances in the chondroprotective effects of traditional Chinese medicine-derived monomeric compounds through pathway activation or inhibition, and discusses current research limitations and future directions to inform their clinical translation for OA treatment.
Source: Frontiers in Medicine
Authors: Jun Li, Ming Tian, Wei Dai, Mingpeng Shi, Xiangyang Leng
Language: English
Subfield: Rheumatology
Field: Medicine
Domain: Health Sciences
Open Access status: gold
Estimated APC paid: $3,801
OpenAlex ID: W7226032849
